(1)連結純損益計算書
|
(単位:百万円)
|
|
|
|
前連結会計年度
(自 2024年4月1日
至 2025年3月31日)
|
|
当連結会計年度
(自 2025年4月1日
至 2026年3月31日)
|
|
売上収益
|
|
1,912,323
|
|
2,139,245
|
|
売上原価
|
|
△349,206
|
|
△408,426
|
|
売上総利益
|
|
1,563,117
|
|
1,730,820
|
|
|
|
|
|
|
|
販売費及び一般管理費
|
|
△843,032
|
|
△860,312
|
|
研究開発費
|
|
△327,651
|
|
△314,827
|
|
無形資産償却費
|
|
△136,762
|
|
△135,982
|
|
無形資産譲渡益
|
|
1,049
|
|
4,349
|
|
持分法による投資損益
|
|
△259
|
|
△1,775
|
|
その他の収益
|
|
20,344
|
|
32,800
|
|
その他の費用
|
|
△235,768
|
|
△72,440
|
|
営業利益
|
|
41,039
|
|
382,633
|
|
|
|
|
|
|
|
金融収益
|
|
7,874
|
|
8,026
|
|
金融費用
|
|
△17,677
|
|
△14,072
|
|
税引前利益
|
|
31,237
|
|
376,587
|
|
法人所得税費用
|
|
19,510
|
|
△85,013
|
|
当期利益
|
|
50,747
|
|
291,575
|
|
|
|
|
|
|
|
|
|
|
|
|
|
当期利益の帰属
|
|
|
|
|
|
親会社の所有者
|
|
50,747
|
|
291,535
|
|
非支配持分
|
|
-
|
|
40
|
|
当期利益
|
|
50,747
|
|
291,575
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1株当たり当期利益
|
|
|
|
|
|
基本的1株当たり当期利益(円)
|
|
28.35
|
|
162.77
|
|
希薄化後1株当たり当期利益(円)
|
|
28.24
|
|
162.22
|
E00920
45030
アステラス製薬株式会社
Astellas Pharma Inc.
通期第3号参考様式 [IFRS](連結)
IFRS
true
cte
cte
2025-04-01
2026-03-31
FY
2026-03-31
2024-04-01
2025-03-31
2025-03-31
1
false
false
false
45030
2026-04-27
45030
2025-04-01
2026-03-31
45030
2025-04-01
2026-03-31
jpigp_cor:CapitalSurplusIFRSMember
45030
2025-04-01
2026-03-31
jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember
45030
2025-04-01
2026-03-31
jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember
45030
2025-04-01
2026-03-31
jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember
45030
2025-04-01
2026-03-31
jpigp_cor:NonControllingInterestsIFRSMember
45030
2025-04-01
2026-03-31
jpigp_cor:OtherComponentsOfEquityIFRSMember
45030
2025-04-01
2026-03-31
jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember
45030
2025-04-01
2026-03-31
jpigp_cor:RetainedEarningsIFRSMember
45030
2025-04-01
2026-03-31
jpigp_cor:ShareAcquisitionRightsIFRSMember
45030
2025-04-01
2026-03-31
jpigp_cor:ShareCapitalIFRSMember
45030
2025-04-01
2026-03-31
jpigp_cor:TreasurySharesIFRSMember
45030
2026-03-31
45030
2026-03-31
jpigp_cor:CapitalSurplusIFRSMember
45030
2026-03-31
jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember
45030
2026-03-31
jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember
45030
2026-03-31
jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember
45030
2026-03-31
jpigp_cor:NonControllingInterestsIFRSMember
45030
2026-03-31
jpigp_cor:OtherComponentsOfEquityIFRSMember
45030
2026-03-31
jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember
45030
2026-03-31
jpigp_cor:RetainedEarningsIFRSMember
45030
2026-03-31
jpigp_cor:ShareAcquisitionRightsIFRSMember
45030
2026-03-31
jpigp_cor:ShareCapitalIFRSMember
45030
2026-03-31
jpigp_cor:TreasurySharesIFRSMember
45030
2024-04-01
2025-03-31
45030
2024-04-01
2025-03-31
jpigp_cor:CapitalSurplusIFRSMember
45030
2024-04-01
2025-03-31
jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember
45030
2024-04-01
2025-03-31
jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember
45030
2024-04-01
2025-03-31
jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember
45030
2024-04-01
2025-03-31
jpigp_cor:NonControllingInterestsIFRSMember
45030
2024-04-01
2025-03-31
jpigp_cor:OtherComponentsOfEquityIFRSMember
45030
2024-04-01
2025-03-31
jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember
45030
2024-04-01
2025-03-31
jpigp_cor:RetainedEarningsIFRSMember
45030
2024-04-01
2025-03-31
jpigp_cor:ShareAcquisitionRightsIFRSMember
45030
2024-04-01
2025-03-31
jpigp_cor:ShareCapitalIFRSMember
45030
2024-04-01
2025-03-31
jpigp_cor:TreasurySharesIFRSMember
45030
2025-03-31
45030
2025-03-31
jpigp_cor:CapitalSurplusIFRSMember
45030
2025-03-31
jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember
45030
2025-03-31
jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember
45030
2025-03-31
jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember
45030
2025-03-31
jpigp_cor:NonControllingInterestsIFRSMember
45030
2025-03-31
jpigp_cor:OtherComponentsOfEquityIFRSMember
45030
2025-03-31
jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember
45030
2025-03-31
jpigp_cor:RetainedEarningsIFRSMember
45030
2025-03-31
jpigp_cor:ShareAcquisitionRightsIFRSMember
45030
2025-03-31
jpigp_cor:ShareCapitalIFRSMember
45030
2025-03-31
jpigp_cor:TreasurySharesIFRSMember
45030
2024-03-31
45030
2024-03-31
jpigp_cor:CapitalSurplusIFRSMember
45030
2024-03-31
jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember
45030
2024-03-31
jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember
45030
2024-03-31
jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember
45030
2024-03-31
jpigp_cor:NonControllingInterestsIFRSMember
45030
2024-03-31
jpigp_cor:OtherComponentsOfEquityIFRSMember
45030
2024-03-31
jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember
45030
2024-03-31
jpigp_cor:RetainedEarningsIFRSMember
45030
2024-03-31
jpigp_cor:ShareAcquisitionRightsIFRSMember
45030
2024-03-31
jpigp_cor:ShareCapitalIFRSMember
45030
2024-03-31
jpigp_cor:TreasurySharesIFRSMember
iso4217:JPY
iso4217:JPY
xbrli:shares
xbrli:pure